Protocols
SAAI
Therapy for Advanced Soft Tissue Sarcoma Using DOXOrubicin, Ifosfamide-Mesna
SAAI3
3-day DOXOrubicin – ifosfamide - mesna for use in Patients with Advanced Soft Tissue Sarcoma
SAAJA
DOXOrubicin for Adjuvant Use for Patients with Non-Metastatic Operable Large High Grade Soft Tissue Sarcoma
SAAJADIC
Adjuvant Treatment of Patients with Soft Tissue Sarcoma using DOXOrubicin and Dacarbazine
SAAVA
Therapy for Advanced Soft Tissue Sarcoma Using DOXOrubicin
SAAVERIB
Palliative Therapy for Metastatic Sarcoma using eriBULin
SAAVGEMD
Therapy for Soft Tissue Sarcomas Using Gemcitabine and DOCEtaxel
SAAVI
Therapy for Advanced Soft Tissue Sarcoma Using Ifosfamide
3-day Ifosfamide for Use in Patients with Advanced Soft Tissue Sarcoma
SAAVADIC
Treatment of Patients with Soft Tissue Sarcoma Using DOXOrubicin and Dacarbazine
SAAVTW
Metastatic or Unresectable Angiosarcoma using Weekly PACLitaxel (3 Weeks out of 4 Weeks Schedule)
SADTIC
High Dose Single Agent Dacarbazine (DTIC) for Metastatic Soft Tissue Sarcoma
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Desmoplastic Small Round Cell Tumour (DSRCT) Using CISplatin
SATEMBEV
Therapy for Advanced Solitary Fibrous Tumours and Hemangiopericytoma Using Temozolomide and Bevacizumab
Adjuvant Therapy for Rhabdomyosarcoma Using vinCRIStine, Dactinomycin, and Cyclophosphamide
SAVDCM
(deleted 01 Jan 2021)
Top
SAAJGI
Adjuvant Treatment of C-Kit Positive High Risk Gastrointestinal Stromal Cell Tumours Using Imatinib
SAAVGI
Treatment of Advanced C-Kit Positive and C-Kit Negative Gastrointestinal Stromal Cell Tumours (GISTs) Using iMAtinib
SAAVGIDD
Treatment of Advanced c-Kit Positive Gastrointestinal Stromal Cell Tumours (GISTs) Using 800 mg Dosing of imatinib
SAAVGR
Third Line Treatment of Advanced Gastrointestinal Stromal Cell Tumours (GISTs) Using Regorafenib
SAAVGRIP
Fourth-Line Therapy of Advanced Gastrointestinal Stromal Cell Tumours (GIST) using Ripretinib
SAAVGS
Second Line Treatment of Advanced C-Kit Positive Gastrointestinal Stromal Cell Tumours (GISTs) After Imatinib Using Sunitinib
Top
SAAJAP
Adjuvant Therapy for Osteosarcoma Using DOXOrubicin and CISplatin
SAAVAP
Therapy of Advanced Osteosarcoma Using DOXOrubicin and CISplatin
SAAVOR
Treatment of Relapsed or Refractory Advanced Osteosarcoma using Regorafenib
Top
SAMV
Palliative Therapy for Aggressive Fibromatosis Using Weekly or Alternate Week Methotrexate and vinBLAstine Intravenously
SATAM
Therapy for Recurrent Desmoid Tumours/Aggressive Fibromatosis Using Tamoxifen
Top
SAALT2W
Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vinCRIStine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at TWO Weekly Intervals for Newly Diagnosed Ewing's Sarcoma/ Ewing’s Family of Tumours, Desmoplastic Intra-abdominal Small Round Blue Cell tumour or Rhabdomyosarcoma
SAALT3W
Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vinCRIStine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at THREE Weekly Intervals for Newly Diagnosed Ewing's Sarcoma/ Ewing’s Family of Tumours, Desmoplastic Intra-abdominal Small Round Blue Cell tumour or Rhabdomyosarcoma
3-Day Etoposide & Ifosfamide-Mesna for Patients with Advanced Soft Tissue or Bony Sarcomas
SAAVTC
Treatment of Recurrent/refractory Neuroblastoma, Ewing's Sarcoma, Osteogenic Sarcoma or Rhabdomyosarcoma with Topotecan/Cyclophosphamide
SAIME
Etoposide, Ifosfamide-Mesna (SAIME) for Use in Sarcomas
SAVAC
Treatment of Sarcomas with vinCRIStine, DOXOrubicin and Cyclophosphamide (SAVAC)
SAVACM
Treatment of Sarcomas with Pelvic Primaries or Chemotherapy Induced Hematuria Using vinCRIStine, DOXOrubicin, Cyclophosphamide and Mesna
Top
KSLDO
Therapy of Kaposi Sarcoma Using DOXOrubicin Pegylated Liposomal (CAELYX)
Top
KSVB
Therapy for Kaposi Sarcoma Using vinBLAstine-vinCRIstine
SANADENO
Denosumab for Neoadjuvant Use in Patients with Non-Metastatic Operable Giant Cell Tumour of the Bone
Top
